Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

7 questions to ask when evaluating a noninferiority trial.

Mounsey A, Viera AJ, Dominik R.

J Fam Pract. 2014 Mar;63(3):E4-8. No abstract available.

PMID:
24701606
2.

Three-arm noninferiority trials with a prespecified margin for inference of the difference in the proportions of binary endpoints.

Hida E, Tango T.

J Biopharm Stat. 2013;23(4):774-89. doi: 10.1080/10543406.2013.789893.

PMID:
23799810
3.

The pros and cons of noninferiority trials.

Pocock SJ.

Fundam Clin Pharmacol. 2003 Aug;17(4):483-90.

PMID:
12914552
4.

Design and analysis of non-inferiority mortality trials in oncology.

Carroll K, Milsted B, Lewis JA.

Stat Med. 2004 Sep 15;23(17):2771-4; author reply 2774-8. No abstract available.

PMID:
15316946
5.

FDA signals it's open to drug trials that shift midcourse.

Mathews AW.

Wall St J (East Ed). 2006 Jul 10:B1, B8. No abstract available.

PMID:
16858817
6.

[Indirect comparisons].

Ortega Eslava A, Fraga Fuentes MD, Alegre Del Rey EJ, Ventayol Bosch P.

Farm Hosp. 2012 Jul-Aug;36(4):173-5. Epub 2012 Jan 17. Spanish. No abstract available.

PMID:
22257629
7.

Designs for efficient clinical trials.

Simon R.

Oncology (Williston Park). 1989 Jul;3(7):43-9; discussion 51-3. Review.

PMID:
2701811
8.

Non-inferiority trials: the 'at least as good as' criterion with dichotomous data.

Laster LL, Johnson MF, Kotler ML.

Stat Med. 2006 Apr 15;25(7):1115-30.

PMID:
16381070
9.

A sequential phase II/III trial for binary outcomes.

Storer BE.

Stat Med. 1990 Mar;9(3):229-35.

PMID:
2160719
10.

Randomization as a basis for inference in noninferiority trials.

Wiens BL.

Pharm Stat. 2006 Oct-Dec;5(4):265-71.

PMID:
17128425
11.

Power and sample size computations in simultaneous tests for non-inferiority based on relative margins.

Dilba G, Bretz F, Hothorn LA, Guiard V.

Stat Med. 2006 Apr 15;25(7):1131-47.

PMID:
16217842
12.

Overview, hurdles, and future work in adaptive designs: perspectives from a National Institutes of Health-funded workshop.

Coffey CS, Levin B, Clark C, Timmerman C, Wittes J, Gilbert P, Harris S.

Clin Trials. 2012 Dec;9(6):671-80. doi: 10.1177/1740774512461859.

PMID:
23250942
13.

Selective exclusion of treatment arms in multi-arm randomized clinical trials.

Law MG, Emery S.

Stat Med. 2003 Jan 15;22(1):19-30.

PMID:
12486749
14.

Noninferiority testing beyond simple two-sample comparison.

Tsong Y, Chen WJ.

J Biopharm Stat. 2007;17(2):289-308.

PMID:
17365225
15.

Statistical issues in interpreting clinical trials.

DeMets DL.

J Intern Med. 2004 May;255(5):529-37. Review.

16.

Commentary: The debate on non-inferiority trials: 'when meta-analysis alone is not helpful'.

Liberati A, D'Amico R.

Int J Epidemiol. 2010 Dec;39(6):1582-3. doi: 10.1093/ije/dyq197. No abstract available.

PMID:
21113051
17.

Efficacy of experimental treatments compared with standard treatments in non-inferiority trials: a meta-analysis of randomized controlled trials.

Soonawala D, Middelburg RA, Egger M, Vandenbroucke JP, Dekkers OM.

Int J Epidemiol. 2010 Dec;39(6):1567-81. doi: 10.1093/ije/dyq136. Epub 2010 Sep 13.

PMID:
20837637
18.

Evaluating equivalence and noninferiority trials.

Dasgupta A, Lawson KA, Wilson JP.

Am J Health Syst Pharm. 2010 Aug 15;67(16):1337-43. doi: 10.2146/ajhp090507.

PMID:
20689122
19.

Test for the consistency of noninferiority from multiple clinical trials.

Yan X, Wang MC, Su X.

J Biopharm Stat. 2007;17(2):265-78.

PMID:
17365223
20.

Randomized clinical trial design for assessing noninferiority when superiority is expected.

Freidlin B, Korn EL, George SL, Gray R.

J Clin Oncol. 2007 Nov 1;25(31):5019-23.

PMID:
17971602

Supplemental Content

Support Center